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Abstract
Background: The optimal decontamination method for needle-free connectors is still unresolved. The objective of
this study was to determine if a continuous passive disinfection cap is as effective as standard cleaning for the
microbial decontamination of injection ports of two types of needle-free connectors.
Methods: The injection ports of needle-free connectors were inoculated with Staphylococcus aureus and allowed to
dry. Disinfection caps containing 70% (v/v) isopropyl alcohol (IPA) were attached to the connectors for one, three or
7 days and were compared with needle-free connectors cleaned with 2% (w/v) chlorhexidine gluconate (CHG) in
70% (v/v) IPA. The number of S. aureus remaining on the injection ports was evaluated. Median log10 reductions
and 95% confidence interval (CI) were calculated and data analyzed using the Mann-Whitney test.
Results: The application of the disinfection cap resulted in a significantly higher reduction in S. aureus than the 2%
(w/v) CHG in 70% (v/v) IPA wipe, achieving a > 5 Log10 reduction in CFU at each time point.
Conclusions: The disinfection caps resulted in a significantly higher reduction in S.aureus on the injection ports
when compared to the use of a 2% (w/v) CHG in 70% (v/v) IPA wipe. This offers an explanation for the lower rates
of central-line associated bloodstream infection (CLABSI) associated with the use of disinfection caps reported in
clinical studies.
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Background
There have been varying reports on the rates of blood-
stream infection (BSI) associated with needle-free connec-
tors including an increase in incidence following a change
from split-septum connectors to mechanical connectors
[1]. The Centers for Disease Control and prevention
(CDC) has subsequently recommended that when needle-
less systems are used, a split-septum valve may be pre-
ferred over some mechanical valves [2]. Furthermore, The
Society for Healthcare Epidemiology of America (SHEA)
and the Infectious Diseases Society of America (IDSA)
advised that positive-pressure needleless connectors with
mechanical valves should not be used before a thorough
assessment of risks, benefits, and education regarding
proper use [3]. The FDA requested that manufacturers of
positive-displacement devices should conduct post-market
surveillance to demonstrate that their devices were not
associated with an increased risk of BSI compared to other
types of device. A SHEA/IDSA practice update
subsequently stated that the optimal needle-free con-
nector design for the prevention of infection was still un-
resolved and an assessment of risks, benefits and
education was again recommended [4].
Many factors have been attributed to the level of infec-
tion risk associated with needle-free connectors and in-
cludes the efficacy of disinfection of the injection ports
[5]. It has also been suggested that surface disinfection
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of needle-free connectors is not intuitive which may lead
to non-compliance [5].
Caps which attach to injection ports of needle-free
connectors incorporating disinfectants have been devel-
oped. Menyhay and Maki described such a device con-
taining 2% chlorhexidine gluconate (CHG) in 70%
isopropyl alcohol (IPA) in 2006 [6]. The caps act as pas-
sive disinfection devices which are designed to ensure
that needle-free connectors are always clean.
Several clinical studies have evaluated the use of these
passive disinfection devices, all of which demonstrate
benefits including significant reductions in the rates of
hub microbial colonisation [7], and central-line associ-
ated bloodstream infections (CLABSI) [8–12].
Whilst these studies represent the clinical scenario
whereby adherence to decontaminating the needle-free
connector may not always be optimal, they do not inves-
tigate the efficacy of a defined cleaning method com-
pared to passive disinfection caps under optimal,
controlled conditions.
The aim of the study was to determine under con-
trolled laboratory conditions whether a commercially
available continuous passive disinfection cap which con-
tains 70% (v/v) IPA was as effective for microbial decon-
tamination of two different needle-free connectors when
compared to defined standard cleaning with a 2% (w/v)
CHG in 70% (v/v) IPA wipe.
Methods
Needle-free connectors and cleaning devices
The needle-free connectors used in this study were a
neutral displacement connector - MicroClave™ (ICU
Medical) and a positive-displacement connector - Care-
Site™ (BBraun). Curos® caps containing 70% (v/v) IPA
(3 M Healthcare) were compared to 2% (w/v) CHG in
70% (v/v) IPA wipes (Sani-cloth CHG 2%, PDI) for de-
contamination of the needle-free connectors.
Contamination of needle-free connectors
An overnight culture of Staphylococcus aureus National
Collection of Type Cultures (NCTC) 6538 on tryptic soy
agar (Oxoid) was used to prepare a 1 × 108 CFU/mL
suspension in tryptone sodium chloride (1 g/L tryptone
[Oxoid], 8.5 g/L NaCl [Sigma-Aldrich] in distilled water)
containing 3 g/L bovine albumin faction V [VWR
International] and 3 ml/L defibrinated sheep blood [TCS
Biosciences] in accordance with BS EN 16615:2015 [13].
Following one activation of each connector, the external
injection port of each sterile needle-free connector were
inoculated with a 50 μL suspension containing at least 5 ×
106 CFU of S. aureus and allowed to air dry for 4 h at 20 °
C. Whilst the high inoculum of S.aureus used in this study
would not be expected in the clinical scenario, it permitted
the identification of any differences present between the
two decontamination methods, was also representative of
European standard antiseptic test conditions [13], and
simulated a worst-case scenario in the clinical situation.
Evaluation of the variability in wiping technique by
different operators
Needle-free connectors were cleaned for 15 s (through 180°
15 times) with a 2% (w/v) CHG in 70% (v/v) IPA wipe and
allowed to dry for 30 s (this method was completed inde-
pendently by two different experienced operators). A total
of 54 of each type of needle-free connnector were studied
(27 of each needle-free connector by each operator).
Evaluation of the prolonged effect of the
decontamination procedures
Disinfection caps were attached to the needlefree-
connectors for 1, 3 or 7 days and were compared with
needle-free connectors cleaned with a 2% (w/v) CHG in
70% (v/v) IPA wipe. All the needle-free connectors were
subsequently left at 20 °C in air for 1, 3 or 7 days. A total
of 54 of each needle-free connector were studied per
time point following each decontamination procedure.
An identical number of control needle-free connectors
which were contaminated as above and which were not
decontaminated were also similarly studied and acted as
positive controls for each sampling point.
Evaluation of the effect of a pre- and post-device
activation wipe
Following contamination with S. aureus, 54 of each type
of needle-free connector were cleaned as above for 15 s
with a 2% (w/v) CHG in 70% (v/v) IPA wipe and allowed
to dry for 30 s. These were then incubated for 7 days at
20 °C and then cleaned again with a 2% (w/v) CHG in
70% (v/v) IPA wipe prior to microbiological sampling.
Microbiological sampling of needle-free connectors
Needle-free connectors were immersed into bijous con-
taining 1 mL of neutralizing solution consisting of 30 g/
L Tween 80, 30 g/L saponin, 3 g/L lecithin, 1 g/L L-histi-
dine, 5 g/L sodium thiosulphate in tryptone sodium
chloride (all VWR International). Nullification of anti-
microbial activity and non-microbial toxicity was verified
prior to commencement of the study (unpublished data).
The bijous were then sonicated for 10 min at 50 Hz.
The entire volume of neutralizing solution was inocu-
lated (in addition to dilutions from positive control con-
nectors) onto chromogenic S. aureus plates (ChromID S.
aureus [Biomerieux]) in duplicate.
Sample size calculation and statistical analysis
The aim of the study sample size was to demonstrate that
each decontamination method achieved a 5 log10 reduc-
tion in the number of S. aureus (or 99.999% reduction).
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Based on preliminary work, it was concluded that 54 of
each type of needle-free connector in each scenario should
give at least a 90% chance of achieving a 5 log10 reduction
in CFU. Median log10 reductions and 95% confidence
interval (CI) were calculated and data analyzed using the
Mann-Whitney test. The level of significance was < 0.05.
Results
CFU counts on positive control needle-free connectors
The minimum CFU count on the controls (the needle-
free connectors which were not decontaminated after in-
oculation with S. aureus) during the study was 5.17 log10
CFU for MicroClave™ and 5.49 log10 CFU for CareSite™
therefore total kill (TK) always represented a ≥ 5.17 or ≥
5.49 log10 CFU reduction, respectively.
Evaluation of the variability in wiping technique by
different operators
There was no significant difference between the two opera-
tors in terms of log10 CFU reduction of S. aureus following
15 s decontamination with a 2% (w/v) CHG in 70% (v/v)
IPA wipe and drying for 30 s for both the MicroClave™ (4.
69, 95% CI = 3.56–5.29 vs 4.61, 95% CI = 3.99–5.21, P = 0.
73) and CareSite™ (5.10, 95% CI = 4.11-TK vs 5.10, 95% CI
= 3.04-TK, P = 0.32). Furthermore, there was no difference
in the overall log10 CFU reduction between the two differ-
ent types of needle-free connectors (P = 0.18 for Micro-
Clave™ and P = 0.70 for CareSite™).
Evaluation of the decontamination procedures on S.
aureus counts.
The median and 95% CI log10 CFU reduction in S. aureus
after decontamination for 15 s with a 2% (w/v) CHG in
70% (v/v) IPA wipe followed by incubation at room
temperature for 1, 3 or 7 days or after application of the
disinfection cap for 1, 3 or 7 days is shown in Table 1. The
application of the disinfection cap resulted in a significantly
higher log10 CFU reduction of the S. aureus than the 2%
(w/v) CHG in 70% (v/v) IPA wipe, achieving a > 5 log10
reduction in CFU at each time point. Furthermore, there
was no difference in the log10 CFU reduction of S. aureus
between the two different types of needle-free connectors
with any decontamination regime at any time-point.
Evaluation of the effect of a pre- and post-device
activation wipe
Decontamination of both types of needle-free device
with a 2% (w/v) CHG in 70% (v/v) IPA wipe both follow-
ing inoculation with S. aureus and following each subse-
quent incubation period resulted in a higher log10 CFU
reduction as compared to only cleaning following con-
tamination for MicroClave™ only (P = 0.009). However,
in line with the above findings, the disinfection cap still
resulted in a significantly higher log10 CFU reduction
(Table 1) as compared to the two decontaminations with
2% (w/v) CHG in 70% IPA (v/v) wipes for both needle-
free connectors (MicroClave™ P = 0.041, CareSite™ P < 0.
0001, median [95% CI] = TK [TK-TK] for both types of
connector).
Discussion
This study demonstrated that under controlled labora-
tory conditions a disinfection cap containing 70% (v/v)
IPA was more effective at reducing microbial contamin-
ation of contaminated injection ports of needle-free con-
nectors when compared to cleaning with 2% (w/v) CHG
in 70% (v/v) IPA wipes even for 15 s. Indeed, the study
demonstrated that the caps were associated with a sig-
nificantly higher log10 CFU reduction than a 2% (w/v)
CHG in 70% (v/v) IPA wipe at 1, 3 and 7 days and a
Table 1 Median (95%CI) log10 reductions of CFU of Staphylococcus aureus on two types of needle-free connectors injection ports
after 1, 3 and 7 days following two decontamination methods
Day Decontamination
method
Connector
studied:
MicroClave®
Comparison of wipe vs
disinfection cap
(P value)
Connector
studied:
CareSite®
Comparison of wipe vs
disinfection cap
(P value)
Comparison of
MicroClave® vs
CareSite® (P value)
1 2% (w/v) CHG in
70% (v/v) IPA wipe
> 6.45a
(4.97-TK)
< 0.0001b TK
(4.29-TK)
< 0.0001b 0.49
Disinfection cap TK
(TK-TK)
TK
(TK-TK)
0.75
3 2% (w/v) CHG in
70% (v/v) IPA wipe
4.66
(4.34–4.95)
< 0.0001b 4.77
(4.39–5.68)
< 0.0001b 0.98
Disinfection cap TK
(TK-TK)
TK
(TK-TK)
0.057
7 2% (w/v) CHG in
70% (v/v) IPA wipe
TK
(TK-TK)
< 0.0001b TK
(5.20-TK)
< 0.0001b 0.15
Disinfection cap TK
(TK-TK)
TK
(TK-TK)
1.00
athe median was half-way between the values of 6.45 and total kill (TK)
bThe reductions were greater for the disinfection cap
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two-clean regime used at 7 days. This was the case for
both types of needle-free connectors tested during this
study, demonstrating the efficacy across more than one
specific device. Indeed, no differences in log10 CFU re-
ductions between these devices were observed. The rea-
sons for this difference in efficacy of the cap versus wipe
is unresolved but may reflect the continuous antimicro-
bial activity of the decontamination offered by the caps
rather than the relatively short time following the wipes.
Another confounding factor is compliance to decontam-
ination of needle-free connectors in clinical practice. Ad-
herence to recommended decontamination procedures
by healthcare workers prior to access of needle-free con-
nectors has been reported to be as low as 10% [14],
whereas with the use of caps compliance has been high
[8–10]. Indeed, the enhanced efficacy of the caps has
also been reflected in decreased rates of CLABSI with
increasing cap compliance [11, 15].
It is therefore conceivable that not only the improved
antimicrobial activity of the caps versus wipes together
with high levels of compliance with disinfection caps may
both in part account for the lower rates of CLABSI associ-
ated with their use reported in previous clinical studies.
It could also be concluded that given the significant
log10 CFU reductions observed with the 2% (w/v) CHG
in 70% (v/v) IPA wipe in this study, there is no require-
ment for the additional efficacy of the disinfection cap.
However, if compliance with the use of wipes is low, the
disinfection caps could prove a useful tool. Furthermore,
since there is concern surrounding potential chlorhexi-
dine- and cross-resistance to antibiotics [15, 16], the use
of a decontamination regime in the absence of chlor-
hexidine (such as the disinfection cap used in this study)
may be appealing.
A potential limitation of this current study is that
the selected single decontamination of the injection
ports with a wipe may not be representative of the
frequency with which this would occur in the clinical
scenario. Similarly, if the disinfection caps were
employed in the inpatient clinical scenario they would
be accessed and replaced more frequently. This would
be the case in clinical areas where IV devices are fre-
quently accessed such as in critical care. However, the
selected decontamination regimen used in this current
study is representative of the outpatient scenario
where central venous catheters may be accessed just
once a week during clinic visits. We therefore consid-
ered that the comparison of the two decontamination
regimes in this study to be representative of this lat-
ter clinical scenario. A further advantage of this ex-
perimental approach was it allowed the longevity of
the antimicrobial activity of the cap to be evaluated.
Besides reports of overcoming compliance issues and
decreased rates of CLABSI there are several other
documented advantages associated with the use of disin-
fection caps. These include time savings [17], healthcare
worker preference [17], a reduction in contamination of
blood cultures [9], and cost savings [8, 9, 11].
All these advantages present a persuasive argument to
utilise these devices in clinical practice.
Conclusion
The results of this study support the SHEA/IDSA practice
special approach recommendation for preventing CLABSI
to ‘use an antiseptic-containing hub/connector cap/port
protector to cover connectors (quality of evidence: I)’ [4].
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